Everything published about Ipamorelin: mechanism, research areas, results, regimens, risks, comparisons — plus the dated Vietnam price and ordering rules.
| Format | Price (index Nov 2, 2026) | Delivery |
|---|---|---|
| 10 mg | from 1 200 000 ₫ | Da Nang ~30 min · Vietnam 1–2 days |
Ipamorelin is a synthetic five-amino-acid peptide that activates the ghrelin receptor. It is studied as a growth-hormone secretagogue: a signal that stimulates release of the body's own growth hormone.
An investigational GHS-R1a agonist. Early pharmacology studies examined GH release and selectivity relative to other hormonal responses; this is different from injecting growth hormone itself.
A selective GH secretagogue with a distinct ghrelin-receptor mechanism, frequently discussed in GH-axis and recovery research.
Pharmacology studies show stimulation of GH release, explaining interest in body composition and recovery. Human trials have also examined postoperative gut recovery; effects on sleep and training outcomes are less established.
Commonly discussed CJC/Ipamorelin protocol: Ipamorelin: 200–300 micrograms subcutaneously before bed, on an empty stomach. Five days on, two days off. Duration: 3–6 months, followed by one month off. Another cycle uses 8–12 weeks on, with four weeks off. These are separate cycle options. The CJC component must be identified as DAC or No DAC because their dosing schedules differ.
Possible effects include injection-site reactions, fluid retention and changes in glucose regulation. Long-term performance-use data are limited.
Ipamorelin targets the ghrelin receptor; CJC compounds target the GHRH receptor. They are often discussed together, with CJC dosing dependent on whether the product contains DAC.
from 1 200 000 ₫ for 10 mg (index Nov 2, 2026); final total confirmed in writing before payment.
No: research material, not a prescription drug; no medical claims.